The preliminary studies on [89Zr]Zr-Trastuzumab in nude mice bearing HER2-positive tumors showed high tumor accumulation and a similar biodistribution pattern with 111In-trastuzumab (13). The gene discussed is ERBB2; the disease is neoplasm.